- Previous Close
0.5100 - Open
0.5100 - Bid 0.4800 x --
- Ask 0.4650 x --
- Day's Range
0.4550 - 0.5150 - 52 Week Range
0.2350 - 0.8700 - Volume
1,997,164 - Avg. Volume
586,873 - Market Cap (intraday)
100.831M - Beta (5Y Monthly) 1.30
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.85
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complimentary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and organic nutraceutical products under the Activated Nutrients brand. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.
www.biomeaustralia.comRecent News: BIO.AX
View MorePerformance Overview: BIO.AX
Trailing total returns as of 1/13/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIO.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIO.AX
View MoreValuation Measures
Market Cap
100.83M
Enterprise Value
99.26M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.36
Price/Book (mrq)
34.73
Enterprise Value/Revenue
7.63
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.84%
Return on Assets (ttm)
-15.27%
Return on Equity (ttm)
-51.47%
Revenue (ttm)
13.01M
Net Income Avi to Common (ttm)
-1.67M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.87M
Total Debt/Equity (mrq)
44.65%
Levered Free Cash Flow (ttm)
177.34k